Spravato® Treatment for Depression

Innovative care. Grounded in safety. Backed by experience.

What is Spravato®?

Spravato® (esketamine) is an FDA-approved nasal spray treatment for:

  • Treatment-resistant depression (TRD)
  • Major depressive disorder (MDD) with suicidal thoughts or behavior

Unlike traditional antidepressants, Spravato works on a different brain pathway — offering relief for patients who haven’t responded to other treatments.

Who is it for?

You may be eligible for Spravato if you:

  • Have tried two or more antidepressants without improvement
  • Struggle with persistent, severe depression
  • Experience suicidal thoughts despite treatment

A referral from your primary care provider or psychiatrist is required.

What to Expect

Spravato is administered in our clinic under close medical supervision. Each treatment session includes:

  1. Clinical check-in — vital signs and mental status
  2. Self-administered nasal spray
  3. Two-hour observation in a quiet, comfortable room
  4. Discharge planning — patients may not drive after treatment

Why Choose TPC?

  • 🧠 Board-certified psychiatric team
  • 🔬 Structured safety protocol
  • 💬 Ongoing therapy and medication support
  • 📑 Insurance coordination and prior auth support

All patients are carefully screened for eligibility, and we work closely with your referring provider throughout treatment.

Insurance Coverage

Most commercial plans (including BCBS and Cigna) cover Spravato® with prior authorization. We’ll check your benefits and handle the paperwork before scheduling.

Medicare coverage varies — we’ll help clarify your options.

Start the Process

📞 Call our intake line at (478) 745-9206
📠 Fax referrals to (250) 999-6620
📍 Location: 3100 Ridge Ave, Macon, GA 31204
📩 CCD referrals accepted via Direct address

[→ Referral Instructions] [→ Contact Us]